Keywords: Bone metastases; Ibandronate; Bisphosphonate; Pain relief
مقالات ISI (ترجمه نشده)
مقالات زیر هنوز به فارسی ترجمه نشده اند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
Efficacy, safety, and compliance of ibandronate treatment for 3 years in postmenopausal Japanese women with primary osteoporosis
Keywords: Adherence; Ibandronate; Osteoporosis; Vitamin D;
Safety and effectiveness of monthly intravenous ibandronate injections in a prospective, postmarketing, and observational study in Japanese patients with osteoporosis
Keywords: Ibandronate; Intravenous; Japan; Osteoporosis; Prospective observational study;
Comparison of effectiveness and safety of ibandronate and minodronate combined with eldecalcitol in primary osteoporosis of women: A 1-year follow-up study
Keywords: Eldecalcitol; Ibandronate; Minodronate; Osteoporosis;
Ibandronate concomitantly blocks immobilization-induced bone and muscle atrophy
Keywords: Ibandronate; Muscle atrophy; Bisphosphonate; Immobilization; Osteoclast; Bone loss;
Ibandronate treatment of diffuse sclerosing osteomyelitis of the mandible: Pain relief and insight into pathogenesis
Keywords: Diffuse sclerosing osteomyelitis; Mandible; Bisphosphonate; Ibandronate; Chronic recurrent osteomyelitis; SAPHO
Nephrotoxicity of ibandronate and zoledronate in Wistar rats with normal renal function and after unilateral nephrectomy
Keywords: 1Ã; group with only one injection; 9Ã; group with nine injections; α-GST; α-glutathione S-transferase; β-NAG; β-N-acetyl-glucosaminidase; AUC; area under the curve; BW; body weight; CREA; creatinine; GFR; glomerular filtration rate; HE; hematoxylin
Treatment with the combination of ibandronate plus eldecalcitol has a synergistic effect on inhibition of bone resorption without suppressing bone formation in ovariectomized rats
Keywords: IBN; ibandronate; ELD; eldecalcitol; OVX; ovariectomized; MCT; medium-chain triglyceride; OCN; osteocalcin; DPD; deoxypiridinorine; BV/TV; bone volume; Tb.Th; trabecular thickness; Tb.Sp; trabecular separation; Tb.N; trabecular number; Oc.S/BS; osteoclast
Loading Dose Ibandronate Versus Standard Oral Ibandronate in Patients With Bone Metastases From Breast Cancer
Keywords: Bisphosphonate; Bone metastases; Bone turnover markers; Breast cancer; Ibandronate;
Effects of intravenous zoledronate and ibandronate on carotid intima-media thickness, lipids and FGF-23 in postmenopausal osteoporotic women
Keywords: Osteoporosis; Zoledronate; Ibandronate; Carotid intima-media thickness; Sclerostin; FGF-23;
Comparison of the Pharmacokinetics, Safety, and Tolerability of Vitamin D3 in DP-R206 (150-mg Ibandronate/24,000-IU Vitamin D3 Tablet) and as Monotherapy (24,000 IU) in Healthy Male Korean Adults
Keywords: ibandronate; osteoporosis; pharmacokinetics; vitamin D3;
Ibandronate increases the expression of the pro-apoptotic gene FAS by epigenetic mechanisms in tumor cells
Keywords: Bisphosphonates; Ibandronate; Epigenetic DNA-methylation; Small GTPases; FAS apoptosis;
Enhanced Oral Absorption of Ibandronate via Complex Formation with Bile Acid Derivative
Keywords: ibandronate; deoxycholic acid; complexation; absorption enhancer; permeability; bioavailability; oral drug delivery;
Determination of renal tissue ibandronate levels in rats with normal and mildly impaired renal function
Keywords: Ibandronate; Renal tissue levels; Renal insufficiency; Rats
Original Full Length ArticleImpact of oral ibandronate 150 mg once monthly on bone structure and density in post-menopausal osteoporosis or osteopenia derived from in vivo μCT
Keywords: HR-pQCT; 3D-pQCT; Microstructure; Ibandronate; Osteoporosis;
Renal safety of ibandronate 6Â mg infused over 15Â min versus 60Â min in breast cancer patients with bone metastases: A randomized open-label equivalence trial
Keywords: Breast cancer; Metastatic disease; Bone metastatic; Diphosphonate; Ibandronate;
Effects of intravenous ibandronate injection on renal function in women with postmenopausal osteoporosis at high risk for renal disease - The DIVINE study
Keywords: Intravenous bisphosphonates; Ibandronate; DIVINE; Postmenopausal osteoporosis; Renal function; Renal disease;
Ibandronate promotes osteogenic differentiation of periodontal ligament stem cells by regulating the expression of microRNAs
Keywords: Ibandronate; Periodontal ligament stem cells; Proliferation; Osteogenic differentiation;
Bisphosphonates for postmenopausal osteoporosis
Keywords: Osteoporosis; Alendronate; Ibandronate; Clodronate; Zoledronic acid; Risedronate;
Ibandronate does not reduce the anabolic effects of PTH in ovariectomized rat tibiae: A microarchitectural and mechanical study
Keywords: Ibandronate; PTH; Additive effect; Bone morphology; Micro-CT
Bisphosphonates in phenytoin-induced bone disorder
Keywords: Alendronate; Ibandronate; Risedronate; Phenytoin; Homocysteine; Bone demineralization
Outcome of Patients With Early Breast Cancer Receiving Nitrogen-Containing Bisphosphonates: A Comparative Analysis From the Metropolitan Detroit Cancer Surveillance System
Keywords: Alendronate; Ibandronate; MDCSS; Risedronate
Regional distribution of spine and hip QCT BMD responses after one year of once-monthly ibandronate in postmenopausal osteoporosis
Keywords: Ibandronate; Bisphosphonate; Quantitative computed tomography (QCT); Postmenopausal osteoporosis; Local BMD distribution; Subcortical bone
Efficacy and safety of monthly ibandronate in men with low bone density
Keywords: Men; Osteoporosis; Treatment; Ibandronate; Bone density
Enzyme-linked immunosorbent serum assays (ELISAs) for rat and human N-terminal pro-peptide of collagen type I (PINP) — Assessment of corresponding epitopes
Keywords: Biochemical markers; Bone formation; PINP; Translational science; Ibandronate; OVX; BDL
The Utility of Changes in Serum Levels of C-Terminal Telopeptide of Type I Collagen in Predicting Patient Response to Oral Monthly Ibandronate Therapy
Keywords: Bisphosphonates; bone densitometry; bone turnover markers; ibandronate; osteoporosis;
Ibandronate dose response is associated with increases in bone mineral density and reductions in clinical fractures: Results of a meta-analysis
Keywords: Bisphosphonates; Clinical fracture; Ibandronate; Non-vertebral fracture; Osteoporosis
Efficacy and safety of monthly oral ibandronate in the prevention of postmenopausal bone loss
Keywords: Low bone mass; Ibandronate; Bisphosphonates; Bone mineral density; Postmenopausal women; Osteoporosis
Oral Ibandronate Preserves Trabecular Microarchitecture: Micro-Computed Tomography Findings From the Oral Ibandronate Osteoporosis Vertebral Fracture Trial in North America and Europe Study
Keywords: Ibandronate; Micro-computed tomography; Postmenopausal osteoporosis; Trabecular architecture;
Metronomic administration of ibandronate and its anti-angiogenic effects in vitro
Keywords: Angiogenesis; Endothelial cells; Ibandronate; Metronomic therapy; Cell growth; Capillary morphogenesis; bFGF
Risk of fracture in women treated with monthly oral ibandronate or weekly bisphosphonates: The eValuation of IBandronate Efficacy (VIBE) database fracture study
Keywords: Bisphosphonates; Hip fracture; Ibandronate; Nonvertebral fracture; Osteoporosis; Vertebral fracture;
High-throughput HPLC-MS/MS method to determine ibandronate in human plasma for pharmacokinetic applications
Keywords: Ibandronate; Bisphosphonates; Liquid chromatography; Tandem mass spectrometry; Derivatization; Plasma; Pharmacokinetics
Rapid Suppression of Bone Resorption Marker Levels With Ibandronate Therapy in a Bisphosphonate-Naïve Population
Keywords: Bisphosphonates; bone turnover markers; CTX; ibandronate; osteoporosis;
Treatment preference for monthly oral ibandronate and weekly oral alendronate in women with postmenopausal osteoporosis: A randomized, crossover study (BALTO II)
Keywords: Ibandronate; Alendronate; Monthly; Preference; Postmenopausal osteoporosis
A model of the public health impact of improved treatment persistence in post-menopausal osteoporosis in France
Keywords: Osteoporosis; Fracture risk; Ibandronate; Mortality; Modelling study
Effects of the bisphosphonate ibandronate on hyperalgesia, substance P, and cytokine levels in a rat model of persistent inflammatory pain
Keywords: Hyperalgesia; Ibandronate; Interleukin-1; Prostaglandin E2; Substance P; Tumor necrosis factor-α;
Bisphosphonate nephrotoxicity
Keywords: pamidronate; zoledronate; ibandronate; acute tubular necrosis; acute kidney injury; collapsing focal segmental glomerulosclerosis
Modélisation de l’impact de santé publique d’une meilleure persistance au traitement de l’ostéoporose post-ménopausique en France
Keywords: Ostéoporose; Risque de fracture; Ibandronate; Mortalité; Étude de modélisationOsteoporosis; Fracture risk; Ibandronate; Mortality; Modelling study
Étude de la préférence des patientes ménopausées ostéoporotiques pour l’ibandronate oral mensuel ou pour l’alendronate oral hebdomadaire : étude randomisée en cross-over (BALTO II)
Keywords: Ibandronate; Alendronate; Mensuel; Préférence; Ostéoporose postménopausiqueIbandronate; Alendronate; Monthly; Preference; Postmenopausal osteoporosis
Vertebral Fracture Diagnosis in the Multinational BONE Study of Oral Ibandronate: Quality Management in Radiology
Keywords: Diagnosis; ibandronate; morphometric; postmenopausal osteoporosis; qualitative; vertebral fracture;
Preclinical evidence for nitrogen-containing bisphosphonate inhibition of farnesyl diphosphate (FPP) synthase in the kidney: Implications for renal safety
Keywords: Bisphosphonates; Nitrogen-containing bisphosphonates; Non-nitrogen containing bisphosphonates; Mevalonate pathway; Farnesyl diphosphate synthase; Nephrotoxicity; Renal; Kidney; Ibandronate; Zoledronate; Pamidronate; Clodronate
Intravenous Ibandronate Rapidly Reduces Pain, Neurochemical Indices of Central Sensitization, Tumor Burden, and Skeletal Destruction in a Mouse Model of Bone Cancer
Keywords: Tumor bone pain; skeletal malignancies; bisphosphonates; ibandronate; nociception
Nueva dosificación de un bifosfonato para la prevención y el tratamiento de la osteoporosis posmenopáusica
Keywords: bifosfonato; ibandronato; dosis mensual; riesgo de fractura vertebral; bisphosphonates; ibandronate; once-monthly; vertebral fractures risk;
Validation of a capillary electrophoresis method for the analysis of ibandronate related impurities
Keywords: Capillary zone electrophoresis; Ibandronate; Impurities determination; Validation
Ibandronate: An IV injection for the treatment for postmenopausal osteoporosis
Keywords: Ibandronate; Bisphosphonate; Postmenopausal osteoporosis; Fracture; Bone mineral density
Bisphosphonate efficacy and clinical trials for postmenopausal osteoporosis: Similarities and differences
Keywords: Bisphosphonates; Osteoporosis; Vertebral fracture; Hip fracture; Nonvertebral fracture; Alendronate; Ibandronate; Risedronate
Update on Osteoporosis Management in Long-term Care: Focus on Bisphosphonates
Keywords: Bisphosphonate; bone mineral density; fracture; ibandronate; osteoporosis;
Vitamin D and ibandronate prevent cancellous bone loss associated with binge alcohol treatment in male rats
Keywords: Alcohol; Osteoporosis; Vitamin D; Ibandronate; Bone
Bisphosphonate action on bone structure and strength: Preclinical and clinical evidence for ibandronate
Keywords: Animal models; Bone structure; Bone strength; Histomorphometry; Ibandronate
Bisphosphonate antifracture efficacy
Keywords: Alendronate; Bone mineral density; Ibandronate; Non-vertebral fracture; Risedronate; Vertebral fracture